ArticleCancer discovery2024

IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity.

Kelly D Moynihan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.